slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 33,181-33,210
Pages 10,126
Rows per page 30
Component
33,181-33,210 of 303,780
36
This appears to be a frame from a video pitch deck or a high-production value slide introducing a team member.1stDibs | IPO Presentation Deck | 47 slides · 1stDibs
Pitch deck Investment bank Beat · Action2 hits
42
The chart uses a combination of bar and line elements to show the progression of LTV/BAC ratios over time.1stDibs | IPO Presentation Deck | 47 slides · 1stDibs
Pitch deck Investment bank Beat · Action2 hits
43
1stDibs | IPO Presentation Deck | 47 slides1stDibs | IPO Presentation Deck | 47 slides · 1stDibs
Pitch deck Investment bank Beat · Action2 hits
01
Advantage Solutions | Investor Presentation Deck | 9 slidesAdvantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Problem2 hits
08
Data from Advantage Sales survey, May 2021.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Loop · Cost Of Inaction2 hits
01
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context2 hits
02
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)2 hits
05
The slide features a high-quality photograph of an Aston Martin car against a brick wall background.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)2 hits
14
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Future Vision (Gain)2 hits
15
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Quick Win Big Bet2 hits
03
The slide uses a central image of a patient/medical team to humanize the strategic pillars.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention2 hits
04
The slide uses a column-based layout to segment the portfolio by therapeutic area.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter2 hits
06
The slide uses a circular timeline graphic to emphasize the 3rd consecutive plenary session achievement.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter2 hits
09
The slide uses a three-pillar framework to organize the strategic approach to lung cancer care.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter2 hits
10
Includes a Kaplan-Meier survival curve and a bar chart showing patient reach growth.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter2 hits
11
The slide uses a color-coded legend to distinguish between approved indications and ongoing trials across the disease continuum.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
12
Slide presents two distinct drug portfolios with corresponding clinical trial results (DESTINY-Lung01 and TROPION-PanTumor01).AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
14
The slide uses a horizontal bar chart format to map drug indications against disease progression stages.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
19
Includes a waterfall chart showing clinical response data and a list of upcoming trial milestones.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
20
The slide uses a matrix-like layout to map clinical trial phases and treatment strategies against patient segments.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
21
The slide uses a three-column layout to compare different drug assets in the pipeline.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
22
The slide uses a grid layout to map drug indications against patient segments and treatment lines.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
26
The slide uses color-coding on the map to represent the three waves of the global rollout.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
27
Data from ELEVATE-TN Phase III trial presented at ASCO 2021.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
28
Source: abstract 7500, ASCO 2021.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
29
The slide uses a three-column layout to categorize drug development projects by their biological target and therapeutic approach.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
34
The slide uses a three-column layout to present distinct clinical trial results for three different drug programs.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
36
The slide uses a three-column layout to categorize different drug discovery and development technologies.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
38
The slide uses a contrast between a yellow table for early-stage pipeline and a dark purple/grey section for late-stage/marketed products.AstraZeneca | Investor Day Presentation Deck | 40 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
04
The slide highlights the operator-led nature of the SPAC and the specific backgrounds of the three key executives.Babylon | SPAC Presentation Deck | 45 slides · Babylon
Pitch deck Investment bank 2 hits